Curaleaf Holdings Future Growth
Future criteria checks 1/6
Curaleaf Holdings is forecast to grow earnings and revenue by 75.4% and 12.6% per annum respectively. EPS is expected to grow by 65.3% per annum. Return on equity is forecast to be 18.2% in 3 years.
Key information
75.4%
Earnings growth rate
65.3%
EPS growth rate
| Pharmaceuticals earnings growth | 65.7% |
| Revenue growth rate | 12.6% |
| Future return on equity | 18.2% |
| Analyst coverage | Good |
| Last updated | 13 Aug 2024 |
Recent future growth updates
Recent updates
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Aug 13
These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively
Jul 19Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%
Jun 14Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%
Jan 19Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?
Dec 11Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?
Sep 08Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?
May 28We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt
Sep 05Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden
May 20Is Curaleaf Holdings (CSE:CURA) A Risky Investment?
Oct 26Loss-Making Curaleaf Holdings, Inc. (CSE:CURA) Set To Breakeven
Mar 20Is Curaleaf Holdings' (CSE:CURA) Share Price Gain Of 188% Well Earned?
Feb 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,754 | 6 | 120 | 235 | 4 |
| 12/31/2025 | 1,548 | -84 | 112 | 188 | 12 |
| 12/31/2024 | 1,398 | -157 | 99 | 168 | 13 |
| 6/30/2024 | 1,360 | -221 | 54 | 134 | N/A |
| 3/31/2024 | 1,353 | -237 | 46 | 111 | N/A |
| 12/31/2023 | 1,347 | -230 | 5 | 75 | N/A |
| 9/30/2023 | 1,342 | -349 | -7 | 72 | N/A |
| 6/30/2023 | 1,334 | -318 | -35 | 71 | N/A |
| 3/31/2023 | 1,312 | -268 | -127 | 9 | N/A |
| 12/31/2022 | 1,275 | -258 | -88 | 46 | N/A |
| 9/30/2022 | 1,244 | -157 | -137 | 22 | N/A |
| 6/30/2022 | 1,234 | -202 | -150 | 11 | N/A |
| 3/31/2022 | 1,232 | -223 | -170 | -7 | N/A |
| 12/31/2021 | 1,196 | -206 | -230 | -58 | N/A |
| 9/30/2021 | 1,118 | -164 | -201 | -27 | N/A |
| 6/30/2021 | 984 | -90 | -237 | -89 | N/A |
| 3/31/2021 | 790 | -57 | -127 | 8 | N/A |
| 12/31/2020 | 627 | -57 | -114 | 12 | N/A |
| 9/30/2020 | 472 | -52 | -110 | -25 | N/A |
| 6/30/2020 | 351 | -50 | -86 | 5 | N/A |
| 3/31/2020 | 282 | -72 | -110 | -23 | N/A |
| 12/31/2019 | 221 | -67 | -120 | -38 | N/A |
| 9/30/2019 | 178 | -57 | -124 | -37 | N/A |
| 6/30/2019 | 137 | -84 | -121 | -50 | N/A |
| 3/31/2019 | 103 | -64 | -101 | -45 | N/A |
| 12/31/2018 | 77 | -56 | -78 | -33 | N/A |
| 9/30/2018 | 51 | -40 | -49 | -20 | N/A |
| 6/30/2018 | 36 | -6 | -33 | -10 | N/A |
| 3/31/2018 | 25 | -3 | N/A | -10 | N/A |
| 12/31/2017 | 19 | -3 | N/A | -8 | N/A |
| 12/31/2016 | 4 | 0 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CURA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CURA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CURA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CURA's revenue (12.6% per year) is forecast to grow faster than the Canadian market (6.4% per year).
High Growth Revenue: CURA's revenue (12.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CURA's Return on Equity is forecast to be low in 3 years time (18.2%).